InterAx platform is shortening the time and cost to discover new effective treatments and de-risk clinical trials. Our technology combines machine learning with mathematical modelling of cellular reactions and in-vitro laboratory experiments for the design and selection of better drugs.
Products, services, technology
Data sets of time-resolved assays are generated in-house and fed into mathematical models. We assess which critical properties a drug candidate must possess in order to elicit a desired cellular/clinical outcome and we provide suggestions for its chemical optimization.
We collaborate with Pharma to support their own drug discovery efforts. InterAx is open to different collaborative settings.